In a nutshell This review compared the effects of two types of bariatric surgery (weight loss surgery) on type 2 diabetes (T2D) remission over five years. It found that Roux-en-Y gastric bypass (RYGB) led to better diabetes outcomes than sleeve gastrectomy (SG). It also found that both types of surgery led to improvements in T2D. Some background T2D...
Read More
In a nutshell This study compared the safety of two medications, linagliptin (Trajenta) and glimepiride (Amaryl). It found that the medications had the same risk of heart attack, stroke, or heart-related death, while linagliptin was associated with a lower risk of hypoglycemia (dangerously low blood glucose level). Some background There...
Read More
In a nutshell This study looked at the safety and effectiveness of adding dapagliflozin (Forxiga) in poorly controlled type 1 diabetes (T1D). It found that patients treated with dapagliflozin had better blood glucose (sugar) control and more weight loss after 12 months than patients treated with placebo. Some background Dapagliflozin belongs...
Read More
In a nutshell This study compared the traditional diabetic diet (TDD) with a low-carbohydrate diet (LCD) for patients with poorly controlled type 2 diabetes (T2D). They found that the LCD resulted in better blood glucose (sugar) control and reduced need for diabetic medications compared to the TDD. Some background The traditional...
Read More
In a nutshell This study looked at the treatment of type 2 diabetes with either daily or weekly insulin injections. They found that weekly insulin was as safe and effective as daily injections. Some background Glycated hemoglobin (Hba1c) is a measurement of how well a person’s blood sugars are controlled over a 3 month period. This is...
Read More
In a nutshell This study is evaluating the effect of medically tailored meals and nutrition education via tele-health for patients with uncontrolled type 2 diabetes (T2D). The outcomes include changes in blood glucose control, body weight, and confidence in self-managing care. This study is taking place in Philadelphia, Pennsylvania, United...
Read More
In a nutshell This study compared patients with type 2 diabetes (T2D) switching to either insulin glargine 300 (Toujeo) or insulin glargine 100 (Lantus). It found that both types of insulin glargine improved blood glucose control, and insulin glargine 300 had a lower risk of hypoglycemia (dangerously low blood glucose levels) outside of a clinical...
Read More
In a nutshell This article looked at the effectiveness of dulaglutide (Trulicity) compared to insulin glargine (Lantus) for patients with uncontrolled type 2 diabetes (T2D). This study concluded that dulaglutide is more effective for these patients compared to insulin glargine. Some background Metformin is recommended as a first-line treatment for...
Read More
In a nutshell This study evaluated empagliflozin (Jardiance) and linagliptin (Tradjenta) for the treatment of Type 2 diabetes (T2D). This study found that combining both drugs (Glyxambi) was more effective at lowering blood glucose levels than either medication alone, with similar side effects. Some background For patients with T2D, the...
Read More
In a nutshell This study evaluated the safety and effectiveness of a combination treatment between sodium-glucose cotransporter 2 (SGLT) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists for patients with Type 2 diabetes (T2D). This study concluded that combination treatment improved blood glucose control and reduced weight loss for...
Read More
In a nutshell This study evaluated whether adding vildagliptin (Galvus) to metformin (Glucophage) could improve the duration of blood glucose control for patients with newly diagnosed Type 2 Diabetes (T2D). The authors found that this treatment combination improved long-term blood glucose control for these patients. Some background...
Read More
In a nutshell This study compared the safety and effectiveness of oral semaglutide with liraglutide administered via subcutaneous (under the skin) injection in patients with type 2 diabetes (T2D). The authors concluded that both treatments were similarly safe and effective in these patients. Some background Glucagon-like-peptide-1 (GLP1)...
Read More
